1. Academic Validation
  2. Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 2. 12-15 September 2009, San Francisco, CA, USA

Interscience Conference on Antimicrobial Agents and Chemotherapy--49th annual meeting. Part 2. 12-15 September 2009, San Francisco, CA, USA

  • IDrugs. 2009 Nov;12(11):670-2.
Ben Turner 1 Lisa Murch
Affiliations

Affiliation

PMID: 19844847
Abstract

The Interscience Conference on Antimicrobial Agents and Chemotherapy held in San Francisco included topics covering new therapeutic developments for the treatment of infectious diseases. This conference report highlights selected presentations on several Antibiotics in development including a broad-spectrum penem beta-lactam Antibiotic, a novel siderophore monobactam, as well as other novel Antibiotics. Investigational drugs discussed include sulopenem and sulopenem etzadroxil (both Pfizer Inc), BAL-30072 (Basilea Pharmaceutica International Ltd), TP-120 and TP-787 (both Tetraphase Pharmaceuticals Inc), NAI-107 (New Anti Infectives Consortium/NexThera Biosciences) and ABI-200 (AdRem Biotech/US Department of Agriculture).

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-W127442
    99.60%, Volatile Ester Compound